Literature DB >> 2493501

Glomerular mesangial cells in local inflammation. Induction of the expression of MHC class II antigens by IFN-gamma.

M Martin1, R Schwinzer, H Schellekens, K Resch.   

Abstract

Glomerular mesangial cells (MC) were isolated from rats and cultured for a prolonged period of time, resulting in a homogeneous cell population. MC were characterized as belonging to the smooth muscle type. They were negative for MHC class II expression. IFN-gamma and TNF alpha suppressed the proliferation of MC, demonstrating receptors for these cytokines on MC. IFN-gamma or TNF alpha, respectively, enhanced basal MHC class I Ag expression of proliferating cells in culture. The combination of the two cytokines yielded stronger effects. IL-1 beta was ineffective in enhancing MHC class I Ag expression, although MC possessed receptors for this cytokine. IFN-gamma dose dependently induced the expression of MHC class II Ag, while TNF alpha or IL-1 beta were ineffective alone. The combination of IFN-gamma with TNF alpha or IL-1 beta resulted in an enhanced induction of MHC class II Ag, compared to IFN-gamma administration alone. These findings suggest that proliferating mesangial cells of the smooth muscle type may participate in local inflammatory responses or substitute for macrophages by meeting the accessory cell requirement in the interaction with T lymphocytes. Furthermore, the data have important implications for the evaluation of the role of mesangial cells in autoimmune disease of the kidney.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2493501

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

1.  CD4(+) T cells specific to a glomerular basement membrane antigen mediate glomerulonephritis.

Authors:  Jean Wu; John Hicks; Jason Borillo; William F Glass; Ya-Huan Lou
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

2.  Recognition of major histocompatibility complex antigens on cultured human biliary epithelial cells by alloreactive lymphocytes.

Authors:  S L Saidman; R J Duquesnoy; A Zeevi; J J Fung; T E Starzl; A J Demetris
Journal:  Hepatology       Date:  1991-02       Impact factor: 17.425

3.  Modulation of glomerular mesangial cell growth and prostaglandin release by T-lymphocyte products.

Authors:  H H Radeke; B Schwinzer; J von der Ohe; C Bovenkerk; K Resch
Journal:  Agents Actions       Date:  1991-01

4.  Analysis of T cells and major histocompatibility complex class I and class II mRNA and protein content and distribution in antiglomerular basement membrane disease in the rabbit.

Authors:  C Eldredge; S Merritt; M Goyal; H Kulaga; T J Kindt; R Wiggins
Journal:  Am J Pathol       Date:  1991-11       Impact factor: 4.307

5.  Mesangial cell immune injury. Synthesis, origin, and role of eicosanoids.

Authors:  E A Lianos; B A Bresnahan; C Pan
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

6.  Mitogenic effect of platelet-derived growth factor in human glomerular mesangial cells: modulation and/or suppression by inflammatory cytokines.

Authors:  J Floege; N Topley; J Hoppe; T B Barrett; K Resch
Journal:  Clin Exp Immunol       Date:  1991-11       Impact factor: 4.330

7.  Expression of IP-10, a lipopolysaccharide- and interferon-gamma-inducible protein, in murine mesangial cells in culture.

Authors:  M Gómez-Chiarri; T A Hamilton; J Egido; S N Emancipator
Journal:  Am J Pathol       Date:  1993-02       Impact factor: 4.307

Review 8.  The inflammatory function of renal glomerular mesangial cells and their interaction with the cellular immune system.

Authors:  H H Radeke; K Resch
Journal:  Clin Investig       Date:  1992-09

9.  Activated T-lymphocytes induce growth inhibition and prostaglandin E2 release from syngeneic glomerular mesangial cells.

Authors:  H H Radeke; B Schwinzer; K Resch
Journal:  Clin Exp Immunol       Date:  1992-12       Impact factor: 4.330

10.  Interferon-gamma stimulates the secretion of IL-1, but not of IL-6, by glomerular mesangial cells.

Authors:  Y Kakizaki; N Kraft; R C Atkins
Journal:  Clin Exp Immunol       Date:  1993-03       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.